Propel Bio Management, LLC Portfolio Holdings

Propel Bio Management, LLC

  • $154 Billion
  • Q2 2024

Propel Bio Management, LLC has filed its 13F form on August 12, 2024 for Q2 2024 where it was disclosed a total value porftolio of $154 Billion distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Applied Therapeutics Inc. with a value of $30.7B, Plains Gp Holdings LP with a value of $25.8B, T Scan Therapeutics, Inc. with a value of $12.2B, Madrigal Pharmaceuticals, Inc. with a value of $12.1B, and Achieve Life Sciences Inc with a value of $11.5B.

Examining the 13F form we can see an decrease of $17.6B in the current position value, from $172B to 154B.

Propel Bio Management, LLC is based out at Los Angeles, CA

Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $154 Billion
Healthcare: $110 Billion
Energy: $25.8 Billion
Technology: $3.33 Billion
Financial Services: $1.52 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $154 Billion
  • Prior Value $172 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 12, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 4 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Propel Bio Management, LLC Portfolio

Follow Propel Bio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email